Results 11 to 20 of about 16,696 (258)

Neuromuscular block in patients 80 years and older: a prospective, controlled study

BMC Anesthesiology, 2021
Background An increasing number of patients older than 80 years are undergoing anesthesia, but little information is available regarding pharmacodynamic effects of myorelaxants in this population.
Denis Schmartz, Raouf Sghaier, Paul Bernard, Jean François Fils, Thomas Fuchs-Buder   +4 more
doaj   +1 more source

Current use of neuromuscular blocking agents and antagonists in Korea: a 2018 survey. [PDF]

Anesth Pain Med (Seoul), 2019
Kim JS, Han JW, Lee JH, Choi JM, Kim HJ, Sung TY, Kim YB, Shin YS, Yang HS.   +8 more
europepmc   +3 more sources

The latest trend in neuromuscular monitoring: return of the electromyography [PDF]

Anesthesia and Pain Medicine, 2021
To reduce the risk of residual neuromuscular blockade, neuromuscular monitoring must be performed. Acceleromyography (AMG)-based neuromuscular monitoring was regarded as “clinical gold standard” and widely applied.
Wonjin Lee
doaj   +1 more source

Preclinical common data elements for general pharmacological studies (pharmacokinetic sample collection, tolerability, and drug administration). A report of the TASK3‐WG1A General Pharmacology Working Group of the ILAE/AES Joint Translational Task Force

Epilepsia Open, EarlyView., 2023
Abstract Growing concerns over rigor and reproducibility of preclinical studies, including consistency across laboratories and translation to clinical populations, have triggered efforts to harmonize methodologies. This includes the first set of preclinical common data elements (CDEs) for epilepsy research studies, as well as Case Report Forms (CRFs ...
Lisa Coles, Patrick A. Forcelli, Karine Leclercq, Anna‐Maria Katsarou, Brian D. Klein, Heidrun Potschka, Rudiger Koehling, Lauren Harte‐Hargrove, Aristea S. Galanopoulou, Cameron S. Metcalf   +9 more
wiley   +1 more source

The Implementation of Protocol-Based Utilization of Neuromuscular Blocking Agent Using Clinical Variables in Acute Respiratory Distress Syndrome Patients

Critical Care Explorations, 2021
Objectives:. The recent conflicting data on the mortality benefit of neuromuscular blocking agents in acute respiratory distress syndrome and the potential adverse effects of continuous neuromuscular blocking agent necessitates that these medications ...
Sarah Hadique, MD, Varun Badami, MD, Michael Forte, MD, Nicole Kovacic, PharmD, BCCCP, Amna Umer, PhD, Amanda Shigle, PharmD, Jordan Gardo, BSN, RN, CCRN, Rahul Sangani, MD   +7 more
doaj   +1 more source

General Anesthesia for a Patient with Myopathy: a case report [PDF]

Kosin Medical Journal, 2020
GNE, or bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase, myopathy presents with symptoms of foot drop, followed by lower and upper extremity muscle weaknesses and sparing of the quadriceps.
Christine Kang, Ji-hye An, Jae-Young Kwon, Boo-Young Hwang   +3 more
doaj   +1 more source

Postoperative complications with neuromuscular blocking drugs and/or reversal agents in obstructive sleep apnea patients: a systematic review

BMC Anesthesiology, 2018
Background Neuromuscular blocking drugs (NMBD) are administered intra-operatively to facilitate intubation and to achieve muscle relaxation for surgical procedures.
Khawaja Rashid Hafeez, Arvind Tuteja, Mandeep Singh, David T. Wong, Mahesh Nagappa, Frances Chung, Jean Wong   +6 more
doaj   +1 more source

Choice of neuromuscular block reversal agent to reduce postoperative pulmonary complications [PDF]

Anesthesia and Pain Medicine, 2022
The definition of postoperative pulmonary complications (PPCs) is inconsistent in literature; however, PPCs include pulmonary abnormalities that adversely affect patient outcomes, such as respiratory failure, atelectasis, pneumonia, pleural effusion, and
Sung-Ae Cho, Tae-Yun Sung
doaj   +1 more source

Association between neuromuscular blocking agent use and outcomes among out-of-hospital cardiac arrest patients treated with extracorporeal cardiopulmonary resuscitation and target temperature management: A secondary analysis of the SAVE-J II study

Resuscitation Plus, 2023
Background: Neuromuscular blocking agents are used to control shivering in cardiac arrest patients treated with target temperature management. However, their effect on outcomes in patients treated with extracorporeal cardiopulmonary resuscitation is ...
Masatoshi Uchida, Migaku Kikuchi, Yasuo Haruyama, Toru Takiguchi, Toru Hifumi, Akihiko Inoue, Tetsuya Sakamoto, Yasuhiro Kuroda   +7 more
doaj  

Comparison of the neuromuscular effects of two infusion rates of rocuronium in anesthetized pigs

Acta Veterinaria Scandinavica, 2022
Background: Neuromuscular blocking agents are frequently administered to pigs used for research. In humans, administration of the drugs is not without risk and may result in accidental awareness under general anaesthesia and postoperative residual ...
Kamilla Pedersen, Linda Loisa Kruhøffer, Jens Lykkesfeldt, Birgitte Saima Kousholt   +3 more
doaj   +1 more source